Retatrutide — Triple Receptor Agonist Peptide
⚠️ FOR RESEARCH PURPOSES ONLY — NOT FOR HUMAN USE
Retatrutide is a novel triple agonist peptide targeting GLP-1, GIP, and Glucagon receptors simultaneously. It is being investigated in research settings for its potential in metabolic regulation and weight management pathways.
Potential Research Areas
- Weight management research
- Metabolic regulation
- Appetite signaling pathways
Available Sizes
- 5mg vial
- 10mg vial
- 15mg vial
Storage
- Refrigerate after reconstitution
- Protect from light
Disclaimer: For laboratory and research purposes only. Not intended for human consumption.
